TNF PHARMACEUTICALS |
USA |
Gesundheit |
US62856X3008 / A41E0S |
DQS (Frankfurt) / TNFA (NASDAQ) |
FRA:DQS, ETR:DQS, DQS:GR, NASDAQ:TNFA |
- |
https://tnfpharma.com/ |
TNF Pharmaceuticals, Inc. is a clinical-stage phar..
>Volltext.. |
11.18 Mio. EUR |
13.47 Mio. EUR |
- |
-7.2 Mio. EUR |
-5.96 Mio. EUR |
-222.36 EUR |
- |
0.18 Mio. EUR |
-7.84 Mio. EUR |
0.69 |
- |
60.9% |
- |
- |
- |
- |
TNF PHARMACEUTICALS, TNF PHARMA, TNF PHARMACEUTICAL |
18.10.25 |
|